Nicotine - Effects of Messaging: Difference between revisions
Adding content |
Adding content |
||
Line 3: | Line 3: | ||
[[File:Nicotine Pro Con messaging 2.png|center|]] | [[File:Nicotine Pro Con messaging 2.png|center|]] | ||
<br> | <br> | ||
<big>'''For more information on stigmatizing people who smoke, please see our [https://safernicotine.wiki/mediawiki/index.php/Nicotine_-_Stigma page about stigma.]'''</big> | |||
<br> | <br> | ||
=Positive Outcomes= | =Positive Outcomes= | ||
Line 19: | Line 20: | ||
**Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297 | **Citation: Lillian Brinken, Kate Shiells, Stuart G Ferguson, Stefania Franja, Anna Blackwell, Claire Braboszcz, Olivia M Maynard, Harnessing hope and bolstering knowledge of how to quit: a qualitative investigation of including efficacy content in tobacco risk communication via daily SMS, Nicotine & Tobacco Research, 2024;, ntae297, https://doi.org/10.1093/ntr/ntae297 | ||
***Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest. | ***Acknowledgement: This study was supported by an ESRC New Investigator‘s Award, awarded to Dr Olivia Maynard (ES/R003424/1) and Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7). Stuart Ferguson has provided expert advice to various pharmaceutical companies and has received researcher-initiated project grant funding (through the GRAND initiative) and travel funds from Pfizer. These companies are not involved in the current study. All other project team members report no conflicts of interest. | ||
===2019: [https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14696 The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology]=== | |||
*"Messages that elicit negative stereotypes of smokers operated as ‘smoking-promoting messages’ in the context of our controlled laboratory investigation." | |||
*[https://sci-hub.se/10.1111/add.14696 PDF of paper] | |||
**Citation: Cortland, C. I., Shapiro, J. R., Guzman, I. Y., & Ray, L. A. (2019). The ironic effects of stigmatizing smoking: combining stereotype threat theory with behavioral pharmacology. Addiction. doi:10.1111/add.14696 | |||
***Acknowledgement: This research was funded by a Tobacco-Related Disease Research Program (20XT-0154) grant awarded to the first and last authors. The authors would like to thank Spencer Bujarski for his assistance with the analyses. |